CBD Life Sciences, Inc. (CBDL) Distributes NEW Infused Gummies Nationwide

SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announced today that the company is taking an innovative approach by introducing a product with Delta-8 and Delta-9.

LBC Bioscience Inc. dominates the competition again by creating new products along with continuous experimentation, and this product is a huge step forward for the company’s overall growth! The delicious green apple-flavored product the company is introducing are gummies infused with 15 MG of Delta-8 and 10 MG of Delta-9 per gum and will come in a 15-count jar. This specific product is great for easing your mind and keeping you focused at the same time! All products are carefully blended to ensure consistency along with third party lab testing for verification. This product will be available in store starting today with the LBC website to follow in the coming days.

President and CEO Lisa Nelson states, “We have been working diligently to experiment and create a new product to offer our consumers and valued shareholders and will continue to keep the public updated going forward!”

The amount of benefits CBD has is huge! These benefits can help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis and ALS. CBD may also benefit pain management that can result from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has also been found to have gastrointestinal benefits with gastrointestinal disorders and complications such as anorexia, cachexia, Crohn’s disease, diabetes, and nausea. It has been said that physical complications/disorders like muscular dystrophy and even immune system deficiencies and other complications like cancer and hypertension, even our body’s way and ability to maintain homeostasis is benefit from CBD.


LBC BIOSCIENCE’s Online Emporium

LBC Bioscience Inc. is already well stocked with some very high quality CBD offerings, all at very reasonable prices. Check out the latest product offerings from LBC Bioscience Inc including: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500MG Premium Berry Drops and a variety of products to to skin care completely new. Or shop our top sellers (based on order frequency) including our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Become a distributor

Large selection of products (50+ items and growing) 100% Made in the USA “Organic and Kosher” products. All products DO NOT contain THC (contain 0.00% THC) Weekly Deals (new deals every week)

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover, etc.

Shareholders and interests can also keep up with LBC Bioscience Inc updates:

Main website of LBC Bioscience Inc a www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and wholesales/retails a full line of organic cannabidiol products including CBD drops, gumballs, honey sticks, pain relief creams, anxiety and sleep supplements, edible , coffee, skin care line, pet line, tablets and more. LBC products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.

Ten Associates LLC
Contact: Thomas E. Nelson
Phone: (480) 326-8577
E-mail: [email protected]
Website: www.tenassociatesllc.com

Forward-looking statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc, Inc. presentations. with OTC Markets, which may identify specific factors that could cause actual results or events to differ materially from those described in the forward-looking statements.

Safe harbor declaration

This release includes forward-looking statements, which are based on certain assumptions and reflect management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, industry changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increased competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenses necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights and tax matters; or other unforeseen matters; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any future ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements

SOURCE: CBD Life Sciences Inc.

Source link

You May Also Like

About the Author: SteveSossin

Welcome! I keep up on all the latest cbd and thc news!